Miguel, a 63-year-old Los Angeles teacher, recently marked the 38th anniversary of his diagnosis with HIV. The doctor had told him he would be dead in a couple of years. He lived fearful that each ...

Doctors at DAP Health have begun administering a new twice-a-year injectable HIV prevention medication, which was approved by the Food and Drug Administration in June. Gilead's drug lenacapavir ...

Journavx (suzetrigine) can cause side effects ranging from mild to serious. More common side effects include muscle spasms and itchiness. If side effects from Journavx become difficult to tolerate, ...

If people living with HIV are on other treatments, including metronidazole (Flagyl) or TB therapy (with Rifadin), alcohol ...

June 19, 2025 – The FDA has approved the first twice-yearly shot to reduce the risk of HIV infections. Originally approved in 2012 as a treatment for people with HIV that no longer responded to ...

The scope of FDA warnings about compounded drugs is narrower than messaging suggests, because they do not center on the ...

Rinvoq can interact with several types of drugs, including immunosuppressants, certain antibiotics, and corticosteroids. Certain conditions or other health factors may increase the risk of ...